GlaxoSmithKline | GSK - Current Liabilities

Stock Price
1,945.50
Daily Change
20.50 1.06%
Monthly
6.87%
Yearly
40.98%
Q1 Forecast
1,839.16

GlaxoSmithKline reported GBP21.33B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
AbbVie USD 39.39B 376M Sep/2025
Alcon AG USD 2.99B 566M Sep/2025
Almirall EUR 298.52M 54.91M Jun/2025
Amgen USD 21.79B 1.32B Sep/2025
argenx SE USD 1.04B 371.99M Jun/2025
AstraZeneca USD 34.05B 518M Sep/2025
Bayer EUR 28.96B 825M Sep/2025
Biogen USD 3.29B 106.3M Sep/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Eli Lilly USD 40.14B 1.12B Sep/2025
Fresenius EUR 9.56B 1.27B Sep/2025
Fresenius Medical Care EUR 5.76B 98.85M Sep/2025
Galapagos EUR 366.56M 36.39M Sep/2025
Genmab DKK 629M 127M Jun/2025
Gilead Sciences USD 12.3B 1.11B Sep/2025
GlaxoSmithKline GBP 21.33B 956M Sep/2025
Glaxosmithkline GBP 28.68B 8.3B Sep/2025
GRIFOLS EUR 2.15B 164.7M Sep/2025
Hikma Pharmaceutical USD 2.06B 78M Jun/2025
Lonza CHF 3.58B 970M Dec/2024
Merck EUR 8.64B 1.22B Sep/2025
Merck USD 28.63B 2.59B Sep/2025
Novartis USD 32B 286M Sep/2025
Novo Nordisk DKK 234.36B 26.84B Sep/2025
Orion EUR 550.5M 9.7M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Philips EUR 7.03B 171M Sep/2025
Recordati EUR 1.04B 24.44M Sep/2025
Regeneron Pharmaceuticals USD 4.43B 758.1M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025
Smith & Nephew USD 1.54B 236M Dec/2025
UCB EUR 3.53B 731M Dec/2024